Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Sharda Cropchem Ltd

| Q3 FY26 Post Result’s Conference Call

BULLISH SENTIMENT

Report Source

⬤3rd Feb 26

Summary : Sharda Cropchem reported strong Q3 FY26 results with record PAT, driven by volume growth and market recovery, maintaining a positive outlook despite registration uncertainties.

Management Perspective positive : We are pleased to report a robust performance driven by strong volume growth. We are very confident that 15% is achievable. We expect the growth in our total revenue to be around 15% to 20% in the year FY '27.

Concall Report Analysis & Insights

Business Overview

  1. Sharda Cropchem reported robust Q3 FY26 performance with highest ever PAT.
  2. Strong volume growth and improved product mix contributed to results.
  3. Global agrochemical market shows signs of recovery with demand revival.
  4. Total revenues grew 39% to INR1,289 crores, with 14% overall volume growth.
  5. Agrochemical segment grew 48%, non-agrochemicals degrew 8.1%.

Future Growth Prospects

  1. Company expects growth momentum to continue in Q4 FY26 and through FY27.
  2. Management is confident of achieving 15% volume growth next year.
  3. Gross margins are expected to be sustainable and may increase further.
  4. Total revenue growth is projected to be around 15% to 20% for FY27.
  5. Planned capital expenditure for FY27 is INR450-500 crores for project pipeline.

Management Insights

  1. Achieved highest-ever annual PAT in 9M FY26, reaching INR362 crores.
  2. Gross margins expanded by 220 basis points to 34.9% in Q3 FY26.
  3. EBITDA grew 59% to INR246 crores, with margins at 19.1%.
  4. Working capital days improved by 48 days to 70 days as of December 2025.
  5. Company is net debt-free with INR826 crores in cash and liquid investments.

Signs of Skepticism

  1. Management states China's export rebate policy does not affect them, but also admits information is not transparent.
  2. Uncertainty regarding product registration timelines (1-7 years) despite significant investment.
  3. Management did not provide specific details on the reasons for NAFTA region de-growth beyond 'unpredictable climate'.

Risk Factors

  1. Product registration process is uncertain and can take 1 to 7 years.
  2. Government authorities frequently add new requirements, increasing registration costs.
  3. NAFTA region experienced de-growth due to unpredictable climate conditions.
  4. China's export rebate policy is non-transparent, making impact assessment difficult.

Good To Know

  1. Total product registrations stand at 3,004, with 1,076 applications in approval stage.
  2. Europe, NAFTA, and LATAM regions constitute 80-90% of the global agrochemical market.
  3. Company declared an interim dividend of INR6 per share.
  4. Top 10 products contribute approximately 43% of the company's revenue.
  5. Forex loss of INR4.53 crores in Q3 FY26 due to foreign currency payable realignment.

Key Drivers

  1. Global agrochemical market demand recovery.
  2. Strong volume growth in Europe region.
  3. Improved product mix and pricing.
  4. Accelerated product registrations globally.

Key Analyst Discussions

Competitive Environment

  1. Few companies invest heavily in product registrations, creating a competitive advantage.
  2. Products must be sourced from approved, registered manufacturing plants.
  3. Company has 3-4 manufacturers per product, providing flexibility and avoiding exploitation.

Market Trends & Consumer Behavior

  1. Global agrochemical market is recovering with demand revival and normalizing inventories.
  2. Prices are slowly moving up after a period of excess liquidity and stock abundance.
  3. Europe's strong growth is attributed to good climate, demand, and timely product supply.
  4. Pre-COVID price levels were higher, but current margins are better due to lower sourcing costs.

Financial Highlights

  1. Q3 PAT grew 366% year-on-year to INR145 crores.
  2. 9M FY26 PAT increased 259% year-on-year to INR362 crores.
  3. FY26 EBITDA margins are expected to be maintained in the 18% to 20% range.
  4. Consolidated tax rate is expected to be in the 18% to 20% range annually.
  5. FY27 capex guidance is INR450-500 crores, subject to uncertainties.

Product Composition

  1. Price and product mix changes contributed 11.6% to the total revenue growth.
  2. Growth in Europe is observed across various molecules, not just a few specific ones.

Strategic Considerations

  1. Product registration approval times are highly uncertain, ranging from 1 to 7 years.
  2. Current registrations: Europe 1,675, NAFTA 321, LATAM 760, Rest of World 248.
  3. Pipeline registrations: Europe 698, NAFTA 100, LATAM 153, Rest of World 125.
  4. Company is not targeting new regions, focusing on deeper penetration in existing markets.
  5. No plans for acquisitions; focus is on increasing dividend payouts.
Sharda Cropchem Ltd (SHARDACROP) Concall Report Analysis & Insights | Dhanarthi